Search - tctmd.com

Displaying 341 - 360 of 427

Sort: Relevancy | Date

Presentation TCT 2013

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Presenter: Soo-Jin Kang

October 29, 2013

Presentation TCT 2013

Case Presentation 1: A Long-Run Restenosis Tale

Presenter: Marin Postu

October 29, 2013

News Conference News TCT 2013

Paclitaxel-Coated Balloons Show Promise in Two Studies

October 29, 2013

Presentation TCT 2013

Restenosis and Stent Thrombosis

Presenter: Kevin Croce

October 28, 2013

Presentation TCT 2013

Longitudinal Stent Deformation and Strut Fracture: Common Causes of Restenosis and Stent Thrombosis?

Presenter: John Ormiston

October 28, 2013

Presentation TCT 2013

Restenosis after Left Main PCI: Frequency, Patterns and Treatment (with Case Vignettes)

Presenter: Adrian Banning

October 28, 2013

Presentation TCT 2013

Predictors of Restenosis and Reocclusion After Successful CTO PCI in the DES Era: Insights from the Florence CTO Registry

Presenter: David Antoniucci

October 28, 2013

Presentation TCT 2013

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Presenter: Bruno Scheller

October 28, 2013

Presentation TCT 2013

Frequency and Time Course of DES Restenosis and Stent Thrombosis: Latest Insights from Randomized Trials and the "Real World"

Presenter: Robert Byrne

October 28, 2013

Presentation TCT 2013

Failure Due to Metallic Cage Jail: How Much Does Impaired Vasoreactivity, Conformability, Compliance Mismatch and Other Mechanisms Contribute to Restenosis and Stent Thrombosis?

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

DES Restenosis: Evaluation and Treatment Options

Presenter: Fernando Alfonso

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

Presentation TCT 2013

Drug-Coated Balloons in the Management of SFA In-Stent Restenosis: The FAIR Randomized Trial

Presenter: Thomas Zeller

October 27, 2013

Presentation TCT 2013

Attacking the Adventitia: Rationale, Feasibility, and Early Signals of Efficacy for Restenosis

Presenter: Christopher Owens

October 27, 2013

Presentation TCT 2013

Use Of Drug-Eluting Balloon For The Treatment Of In-stent Restenosis After Carotid Artery Stenting

Presenter: Piero Montorsi, Antonio Bartorelli, Franco Fabbiocchi, Stefano Galli, Alessandro Lualdi, Paolo Ravagnani, Giovanni Teruzzi, Daniela Trabattoni, Sarah Troiano

January 31, 2013

Presentation TCT 2013

Totally Occluded In-stent Restenosis After Superficial Femoral Artery Stenting does not Worsen the Long-term Outcomes, but tend to Recur Occlusively

Presenter: Sanghoon Shin, Donghoon Choi, Young-Guk Ko

January 31, 2013

$The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...$

Presentation TCT 2013

The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...

Presenter: Tahei Ichinohe, Kazushige Kadota, Haruki Eguchi, Seiji Habara, Hiroyuki Tanaka, Takeshi Tada, Yasushi Fuku, Naoki Oka, Hiroyuki Yamamoto, Satoki Fujii, Tsuyoshi Goto, Kazuaki Mitsudo

January 31, 2013

Presentation TCT 2013

Restenosis after coronary stenting in 10,004 patients with follow-up angiography

Presenter: Salvatore Cassese, Robert Byrne, Julinda Mehilli, Stephanie Schulz, Tomohisa Tada, Lamin King, Susanne Pinieck, Albert Sch?mig, Adnan Kastrati

January 31, 2013

Presentation TCT 2013

Predictors of In Stent Restenosis by Optical Coherence Tomography Derived Tissue Characterization In The Novel In Stent Neointimal Hyperplasia Model Of Familial...

Presenter: Piotr Buszman, Taylor Palmieri, Maxwell Afari, Armando Tellez, Yanping Cheng, Jong Shiuan Yeh, Seung-Jin Oh, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

Paclitaxel Drug Eluting Balloon Versus Standard Angioplasty To Reduce Restenosis In Diabetic Patients With In Stent Restenosis Of The Superficial Femoral And Proximal Popliteal...

Presenter: Francesco Liistro, Paolo Angioli, Guido Bellandi, Leonardo Bolognese, Kenneth Ducci, Italo Porto, Filippo Turini, Giorgio Ventoruzzo

January 31, 2013

Advertisement

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Case Presentation 1: A Long-Run Restenosis Tale

Paclitaxel-Coated Balloons Show Promise in Two Studies

Restenosis and Stent Thrombosis

Longitudinal Stent Deformation and Strut Fracture: Common Causes of Restenosis and Stent Thrombosis?

Restenosis after Left Main PCI: Frequency, Patterns and Treatment (with Case Vignettes)

Predictors of Restenosis and Reocclusion After Successful CTO PCI in the DES Era: Insights from the Florence CTO Registry

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Frequency and Time Course of DES Restenosis and Stent Thrombosis: Latest Insights from Randomized Trials and the "Real World"

Failure Due to Metallic Cage Jail: How Much Does Impaired Vasoreactivity, Conformability, Compliance Mismatch and Other Mechanisms Contribute to Restenosis and Stent Thrombosis?

DES Restenosis: Evaluation and Treatment Options

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Drug-Coated Balloons in the Management of SFA In-Stent Restenosis: The FAIR Randomized Trial

Attacking the Adventitia: Rationale, Feasibility, and Early Signals of Efficacy for Restenosis

Use Of Drug-Eluting Balloon For The Treatment Of In-stent Restenosis After Carotid Artery Stenting

Totally Occluded In-stent Restenosis After Superficial Femoral Artery Stenting does not Worsen the Long-term Outcomes, but tend to Recur Occlusively

The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...

Restenosis after coronary stenting in 10,004 patients with follow-up angiography

Predictors of In Stent Restenosis by Optical Coherence Tomography Derived Tissue Characterization In The Novel In Stent Neointimal Hyperplasia Model Of Familial...

Paclitaxel Drug Eluting Balloon Versus Standard Angioplasty To Reduce Restenosis In Diabetic Patients With In Stent Restenosis Of The Superficial Femoral And Proximal Popliteal...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content